US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HARBOR HEALTH CARE ETF

32.92

-0.8500-2.52%

Volume:2K

Turnover:72.35K

Market Cap:41.97M

PE:- -

High:32.93

Open:32.93

Low:32.90

Close:33.77

52wk High:35.61

52wk Low:27.50

Shares:1.28M

Float Shares:1.28M

Volume Ratio:1.61

T/O Rate:0.17%

Dividend:0.08

Dividend Rate:0.23%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Structure weakness ‘disconnected’ from underlying data, says Jefferies

Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for Hsv Helicase-Primase Inhibitor Program

THOMSON REUTERS

Assembly Biosciences - Assembly Bio Eligible for up to $280 Mln in Milestones and Royalties Outside U.S.

THOMSON REUTERS

Assembly Biosciences - Gs-1179 Expected to Advance into Phase 2 Trial for Genital Herpes by End of 2026

THOMSON REUTERS

Assembly Biosciences - Gilead Retains Sole Right for Clinical Development and Commercialization of Hsv Hpi Program

THOMSON REUTERS

Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback

Gilead Sciences Inc Stock (GILD) Moved Down by 3.26% on Sep 8: Drivers Behind the Movement

Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines

THOMSON REUTERS

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

Mirum Pharmaceuticals Names Rob Myers Chief Medical Officer Effective Sept. 21, 2026

AlzeCure Pharma to Present at Aktiedagen Event in Stockholm

Gilead Sciences (GILD) Receives a Buy from Bernstein

Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids

ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review

Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Lilly Targets Type 1 Diabetes With New Tirzepatide Study: What Investors Should Watch

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Ascendis Pharma Director Lars Holtug Disposes of 236 Shares Worth $62,337.59

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/MEDI/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MEDI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDI\",,,,,undefined,":{"symbol":"MEDI","market":"US","secType":"STK","nameCN":"HARBOR HEALTH CARE ETF","latestPrice":32.92,"timestamp":1789483422160,"preClose":33.77,"halted":0,"volume":2199,"delay":0,"changeRate":-0.025170269469943777,"floatShares":1275000,"shares":1275000,"eps":0,"marketStatus":"Trading","change":-0.85,"latestTime":"09-15 10:51:36 EDT","open":32.93,"high":32.93,"low":32.9,"amount":72351.72449699999,"amplitude":0.000888,"askPrice":32.79,"askSize":300,"bidPrice":32.72,"bidSize":300,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":33.77,"sharesOutstanding":925000,"nav":33.39453,"aum":42578026.12,"dividendRate":0.002293,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.77,"preClose":33.77,"latestTime":"16:10 EDT","volume":7,"amount":236.03,"timestamp":1789416604452,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.61399},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDI\",,,,,undefined,":{"symbol":"MEDI","floatShares":1275000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.61399,"shares":1275000,"dividePrice":0.0755,"high":32.93,"amplitude":0.000888,"preClose":33.77,"low":32.9,"week52Low":27.5,"pbRate":"--","week52High":35.605,"institutionHeld":0,"latestPrice":32.92,"eps":0,"divideRate":0.002293,"volume":2199,"delay":0,"ttmEps":0,"open":32.93,"prevYearClose":31.45,"prevWeekClose":33.3782,"prevMonthClose":34.24,"prevQuarterClose":33.84,"fiveDayClose":33.8616,"twentyDayClose":34.0644,"sixtyDayClose":30.8503},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDI\",params:#limit:5,,,undefined,":[{"date":"2025-12-19","symbol":"MEDI","amount":0.07515,"announcedDate":"2025-12-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-19","defaultRemindTime":1766154600000,"name":"HARBOR HEALTH CARE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-19","currency":"USD","dateTimestamp":1766120400000,"payDate":"2025-12-24"},{"date":"2024-12-20","symbol":"MEDI","amount":0.13455,"announcedDate":"2024-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"HARBOR HEALTH CARE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-26"},{"date":"2023-12-21","symbol":"MEDI","amount":0.4613,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-22","defaultRemindTime":1703169000000,"name":"HARBOR HEALTH CARE ETF","recordDate":"2023-12-27","payableDate":"2023-12-22","currency":"USD","dateTimestamp":1703134800000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDI\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-21","recordDate":"2023-12-22","paymentDate":"2023-12-27","value":0.4613,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-26","value":0.13455,"currency":"USD"},{"executeDate":"2025-12-19","recordDate":"2025-12-19","paymentDate":"2025-12-24","value":0.07515,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDI\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNCR","FHLC","IDNA","GDOC","AZNH","MEDX","SYNB","SURI","MNTL","TBXU","IEIH","BME","WDNA","GNMX","LLYX","PBE","HRTS","SBIO","NVIB","FBT","LFSC","PJP","MEDI","FTXH","MDTX","APXH","GNOM","IBRN","GSKH","BBP","XPH","PTH","RSPH","CURE","FXH","JDOC","JHMH","IBBQ","PINK","PSIL","IBBJ","IBB","MRNY","PBPH","BBH","HYLG","PSCH","BIB","CANC","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666937221","title":"Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for Hsv Helicase-Primase Inhibitor Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666937221","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666937221?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA4XVZNR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBH","IE00B3T34201.USD","TMED","BK4578","LU0234570918.USD","LU0859254822.USD","LU1674673691.USD","IE00BZ1G4Q59.USD","LU0889565916.HKD","LU0122379950.USD","SG9999015945.SGD","SG9999015986.USD","LU1430594728.SGD","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","LU1585245621.USD","IBBQ","IE00B19Z3581.USD","LU0823416689.USD","GILD","LU0965509010.AUD","LU1037948541.HKD","LU1778281490.HKD","SG9999015978.USD","BIB","LU1023059063.AUD","LU0965509283.SGD","LU2357627491.SGD","BK4588","LU1934455277.USD","IE0002270589.USD","LU0289739699.SGD","LU1674673428.USD","LU1061106388.HKD","LU2468319806.SGD","TBXU","BK4550","LU2089984988.USD","LU1839511570.USD","MEDI","ASMB","BMED","LU0109394709.USD","LU1934455194.USD","LU1934455863.HKD","LU0320765992.SGD","SG9999015952.SGD","LU0058720904.USD","BK4566","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666437220","title":"Assembly Biosciences - Assembly Bio Eligible for up to $280 Mln in Milestones and Royalties Outside U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2666437220","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666437220?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA4XVZNR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDI","LU2089984988.USD","BK4578","BK4568","SG9999015952.SGD","ASMB","IE00BKVL7J92.USD","IE00B3T34201.USD","LU1066053197.SGD","LU1934455863.HKD","LU1674673428.USD","LU1066051498.USD","LU0114720955.EUR","LU1934455194.USD","LU0889565916.HKD","IE00BZ1G4Q59.USD","LU0234570918.USD","LU2324357040.USD","GILD","BBH","LU1023059063.AUD","LU1061106388.HKD","LU0965509101.SGD","LU0058720904.USD","TBXU","TMED","LU1430594728.SGD","BK4550","LU1934455277.USD","BK4532","LU0965509283.SGD","LU0109394709.USD","IE00B19Z3B42.SGD","SG9999015978.USD","LU2112291526.USD","IE00B7SZLL34.SGD","BIB","BK4583","LU2468319806.SGD","IBBQ","BK4139","IBB","BK4588","IE00B19Z3581.USD","LU1585245621.USD","LU1839511570.USD","LU1037948897.HKD","LU1571399168.USD","LU0882574055.USD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372203","title":"Assembly Biosciences - Gs-1179 Expected to Advance into Phase 2 Trial for Genital Herpes by End of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372203","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372203?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA4XVZNR:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDI","LU0965509010.AUD","SG9999015986.USD","TBXU","BBH","BIB","LU1674673691.USD","LU2468319806.SGD","ASMB","BK4568","BK4588","IBBQ","LU0320765992.SGD","IE00B7SZLL34.SGD","LU1934455277.USD","LU2087621335.USD","LU2112291526.USD","LU1037948897.HKD","BK4585","BK4532","LU1430594728.SGD","BK4139","LU0234570918.USD","LU0882574055.USD","IE0002270589.USD","SG9999015978.USD","BK4550","LU0109394709.USD","LU1037948541.HKD","LU0289739699.SGD","LU0965508806.USD","LU2089984988.USD","LU2324357040.USD","IBB","LU1934455863.HKD","LU0859254822.USD","LU1057294990.SGD","LU1571399168.USD","LU1839511570.USD","TMED","LU1066051498.USD","GILD","LU1674673428.USD","IE00BSNM7G36.USD","LU1934455194.USD","LU0965509283.SGD","BMED","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666216372","title":"Assembly Biosciences - Gilead Retains Sole Right for Clinical Development and Commercialization of Hsv Hpi Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666216372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666216372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA4XVZNR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1057294990.SGD","LU0320765992.SGD","BIB","LU0861579265.USD","LU2324357040.USD","BBH","BK4532","BK4585","LU0109394709.USD","LU0965509010.AUD","LU1934455863.HKD","TMED","LU0058720904.USD","BK4568","IE0002270589.USD","LU0965509283.SGD","LU0882574055.USD","LU1674673428.USD","BK4139","LU0859254822.USD","MEDI","IE00BKVL7J92.USD","BK4578","LU2112291526.USD","BMED","TBXU","ASMB","LU0114720955.EUR","LU1839511570.USD","LU1674673691.USD","SG9999015978.USD","IBB","LU1430594728.SGD","IE00BSNM7G36.USD","BK4550","LU0889565916.HKD","BK4583","IBBQ","LU1585245621.USD","BK4566","LU1066053197.SGD","SG9999015986.USD","LU1934455277.USD","SG9999015945.SGD","LU0234570918.USD","GILD","LU0122379950.USD","LU2468319806.SGD","LU1037948897.HKD","LU1934455194.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374281","title":"Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374281","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374281?lang=en_us&edition=fundamental","pubTime":"2026-09-09 02:03","pubTimestamp":1788890602,"startTime":"0","endTime":"0","summary":"Cardiovascular disease treatments are potentially lucrative for the pharma industry.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/eli-lilly-stock-lly-falls-on-news-of-competitor-novartis-cholesterol-drug-setback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/eli-lilly-stock-lly-falls-on-news-of-competitor-novartis-cholesterol-drug-setback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823434740.USD","HRTS","ELIL","LU0787776722.HKD","LU0097036916.USD","LU2236285917.USD","IE0004445239.USD","CURE","LU0266013472.USD","FHLC","IE00B1XK9C88.USD","LLYX","LU1629891620.HKD","LU2471134879.HKD","LU2461242641.AUD","LU2602419157.SGD","LU0316494557.USD","AGNG","LU2552382215.SGD","SG9999015986.USD","LU2237443382.USD","LU1720051017.SGD","LU0882574139.USD","SG9999015978.USD","LU0210536198.USD","LU1548497426.USD","IE00BJJMRX11.SGD","LU2361044949.HKD","VHT","BK4516","SGXZ31699556.SGD","IE00BJT1NW94.SGD","IE0001KFT4U8.USD","IE00B7KXQ091.USD","LU0683600562.USD","LU2456880835.USD","LU2237443978.SGD","LU0786609619.USD","IE00BKPKM429.USD","LU1366192091.USD","LU2211815571.USD","LU1804176565.USD","IE00BN29S564.USD","LU2108987350.USD","PPH","LU0471298777.SGD","LU0889565916.HKD","LU0354030511.USD","IE00BK4W5L77.USD","LU2746668461.USD","IYH","LU0689472784.USD","LU1127390331.HKD","LU1917777945.USD","LU2237438978.USD","LU2552382058.USD","LU1868836591.USD","LU1691799644.USD","SG9999013999.USD","WDNA","LU2023250330.USD","IE00BFTCPJ56.SGD","LU0345770993.USD","SG9999015945.SGD","LU1814569148.SGD","LU2360106947.USD","LU0061475181.USD","BK4533","ILDR","LU2271345857.HKD","LU1267930730.SGD","LU0672654240.SGD","LU0385154629.USD","LU1093756325.SGD","LU1232071149.USD","LU2750360997.AUD","IXJ","LU0079474960.USD","IE00BJJMRY28.SGD","LU0320765059.SGD","LU1023059063.AUD","LU0114720955.EUR","LU2756315318.SGD","CANC","LU2237443622.USD","IE00BJLML261.HKD","LU2168564065.EUR","LU1868837300.USD","LU0820561818.USD","SG9999001176.SGD","BK4599","LU2552382132.HKD","IHE","LU0708995401.HKD","LU1280957306.USD","LU2756315664.SGD","LU0106261372.USD","LU2361045086.USD","LU2237443549.SGD","LU2265009873.SGD","LU0174119429.USD","LU0466842654.USD","LU0256863902.USD","LU0640476718.USD","LU0417517546.SGD","SGXZ51526630.SGD","LU0353189763.USD","LU1061106388.HKD","LU1145028129.USD","LLYZ","LU2168564222.USD","LU2264538146.SGD","LU0882574055.USD","LU2746668974.SGD","LU2089283258.USD","IE00B4R5TH58.HKD","LU0823416689.USD","LU2168564149.EUR","LU2168564495.EUR","LLII","LU2471134796.USD","LU1323610961.USD","LU0323591593.USD","LU1064131342.USD","LU2462591350.SGD","LU0820562030.AUD","LU0456855351.SGD","MEDX","GDOC","LU1868836914.USD","LU1551013425.SGD","LU0198837287.USD","IE00B4JS1V06.HKD","LU0158827781.USD","SGXZ81514606.USD","LU2471134523.USD","LU2089284900.SGD","SG9999018865.SGD","LU0006306889.USD","LU0353189680.USD","LU0354030438.USD","GB00BDT5M118.USD","LU0203202063.USD","LU1868836757.USD","FTXH","LU1057294990.SGD","LU0058720904.USD","LU2361044865.SGD","LU2471134952.CNY","SG9999014914.USD","SG9999017495.SGD","IE00BKDWB100.SGD","LU1983299246.USD","SG9999014898.SGD","SG9999018857.SGD","LU1988902786.USD","IE00B775H168.HKD","IE00BFSS8Q28.SGD","LU1035775433.USD","LU2417539215.USD","LU2357305700.SGD","LU2087625088.SGD","LU2237443465.HKD","LU2750360641.GBP","LU1623119135.USD","BK4581","BK4588","LU2028103732.USD","BK4007","IE0005OL40V9.USD","LU2468319806.SGD","SGXZ57979304.SGD","RXL","LU0345770308.USD","OZEM","BK4534","IE00B2B36J28.USD","TRUH","LU0238689110.USD","LU2023250504.SGD","LU0471298694.HKD","LU0203201768.USD","LU2023251221.USD","LU2111349929.HKD","LU2462157665.USD","MHIP","LU0256863811.USD","LU1093756168.USD","IE00BFSS7M15.SGD","LU1979441026.SGD","BK4585","LU2063271972.USD","LU2491050154.USD","SG9999014906.USD","LU0133085943.USD","THNR","LU1712237335.SGD","SG9999014880.SGD","LU1069344957.HKD","IE0002141913.USD","ELIS","LU2896262040.SGD","LU0225283273.USD","LU0964807845.USD","LU0820561909.HKD","LU0289739699.SGD","SGXZ99366536.SGD","XLV","IE00BJJMRZ35.SGD","LU2112291526.USD","SG9999015952.SGD","LU2168563687.JPY","LU0320765992.SGD","LU0096364046.USD","LU0094547139.USD","LU1551013342.USD","LU2324357040.USD","LU0943347566.SGD","LU0823434583.USD","LU0109391861.USD","MEDI","SG9999001176.USD","LU1291159041.SGD","IE00BWXC8680.SGD","IE0009355771.USD","LU0234572021.USD","LU0158827948.USD","LU1720051108.HKD","LU2237443895.HKD","LU1989771016.USD","IE00BK4W5M84.HKD","TMED","LU0109394709.USD","LU2089984988.USD","JDOC","LU0432979614.USD","LU2213496289.HKD","LU2491050071.SGD","LU1974910355.USD","IE00B1BXHZ80.USD","PJP","LU0122379950.USD","LLY","LU2491049909.HKD","IE0004445015.USD","LU1868837136.USD","LU2106854487.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374571","title":"Gilead Sciences Inc Stock (GILD) Moved Down by 3.26% on Sep 8: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374571","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374571?lang=en_us&edition=fundamental","pubTime":"2026-09-09 01:15","pubTimestamp":1788887735,"startTime":"0","endTime":"0","summary":"• Gilead pulled back due to profit-taking following a sustained multi-month rally.\n• Strong second-quarter revenue was driven by flagship HIV and Trodelvy franchises.\n• Analysts maintain Buy ratings with an average price target of $157.79.","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262156548-market-movers-gild-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1674673428.USD","BK4566","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","LU0859254822.USD","LU1934455863.HKD","BK4578","LU2324357040.USD","IE0002270589.USD","LU0965509101.SGD","LU1674673691.USD","LU1057294990.SGD","LU0109394709.USD","LU0965509283.SGD","LU1934455194.USD","LU1061106388.HKD","BK4588","BBH","BK4139","BIB","TBXU","BK4585","LU1934455277.USD","BK4568","IE00BZ1G4Q59.USD","LU0058720904.USD","LU0882574055.USD","LU1066053197.SGD","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","LU0889565916.HKD","LU0320765992.SGD","LU0289739699.SGD","IBB","LU1037948897.HKD","SG9999015945.SGD","LU2089984988.USD","SG9999015986.USD","LU1023059063.AUD","IBBQ","IE00B3T34201.USD","MEDI","TMED","LU0965508806.USD","LU2468319806.SGD","LU2357627491.SGD","LU0122379950.USD","BK4583","LU1430594728.SGD","LU2112291526.USD","GILD","BMED","LU0823416689.USD","LU0114720955.EUR","LU1571399168.USD","LU1066051498.USD","LU1778281490.HKD","SG9999015952.SGD","LU2087621335.USD","LU1839511570.USD","LU1585245621.USD","LU1037948541.HKD","BK4550","IE00B19Z3581.USD","LU0234570918.USD","LU0965509010.AUD","LU0861579265.USD","SG9999015978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666717963","title":"Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2666717963","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666717963?lang=en_us&edition=fundamental","pubTime":"2026-09-09 01:00","pubTimestamp":1788886800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA5WKCFL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0965509283.SGD","BK4585","BIB","BK4532","LU1778281490.HKD","LU0823416689.USD","LU2468319806.SGD","IE0002270589.USD","TMED","IE00BZ1G4Q59.USD","LU1934455194.USD","LU1037948897.HKD","LU2089984988.USD","MEDI","LU2357627491.SGD","BK4550","LU1674673428.USD","LU2087621335.USD","LU1023059063.AUD","LU1066051498.USD","BK4566","IE00B19Z3581.USD","LU0859254822.USD","LU1585245621.USD","LU0882574055.USD","SG9999015986.USD","BK4578","BK4583","LU2112291526.USD","IE00B3T34201.USD","LU0320765992.SGD","IBB","GILD","LU1839511570.USD","IE00BSNM7G36.USD","BBH","IE00B7SZLL34.SGD","LU0965508806.USD","LU1066053197.SGD","LU1057294990.SGD","LU2324357040.USD","IE00BKVL7J92.USD","LU0289739699.SGD","TBXU","LU1674673691.USD","LU0234570918.USD","LU1934455863.HKD","IBBQ","LU0122379950.USD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665637847","title":"Structure Therapeutics reports ACCG-2671, aleniglipron trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665637847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665637847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:36","pubTimestamp":1788871007,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates: ACCG-2671, an oral, non-peptide, small molecule...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","SBIO","GSKH","FHLC","IBBQ","BME","MDTX","RSPH","LLYX","CNCR","CURE","PBE","PJP","JDOC","IBBJ","BIB","CANC","LFSC","SYNB","FTXH","JHMH","PTH","IBRN","BBH","GPCR","TBXU","WDNA","PBPH","NVIB","HYLG","PSCH","SURI","PSIL","IBB","MEDI","BBP","FBT","PINK","FXH","MEDX","MNTL","HRTS","XPH","AZNH","GNMX","APXH","LENZ","GDOC","GNOM","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665237857","title":"Mirum Pharmaceuticals Names Rob Myers Chief Medical Officer Effective Sept. 21, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665237857","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665237857?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:31","pubTimestamp":1788870661,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals names Rob Myers chief medical officer effective Sept. 21, 2026Mirum named Rob Myers as chief medical officer, effective Sept. 21, 2026, to lead global medical and clinical develo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLbq3cV8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","LU0320765992.SGD","BK4583","LU2087621335.USD","LU0289739699.SGD","BIB","LU1674673428.USD","BK4568","LU0889565916.HKD","IBB","IE00BKVL7J92.USD","TMED","TBXU","LU2357627491.SGD","SG9999015978.USD","LU0114720955.EUR","GILD","BK4588","LU1585245621.USD","LU1674673691.USD","IE00B3T34201.USD","SG9999015986.USD","LU1037948897.HKD","LU1057294990.SGD","BBH","IE0002270589.USD","LU0882574055.USD","BMED","BK4578","LU0965509010.AUD","BK4532","LU0965508806.USD","LU2089984988.USD","LU1066051498.USD","IBBQ","LU1571399168.USD","LU1839511570.USD","BK4566","LU0859254822.USD","LU1934455277.USD","LU1778281490.HKD","BK4550","LU1037948541.HKD","BK4585","IE00B19Z3581.USD","LU0965509101.SGD","MEDI","LU2468319806.SGD","MIRM","LU1934455194.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665323952","title":"AlzeCure Pharma to Present at Aktiedagen Event in Stockholm","url":"https://stock-news.laohu8.com/highlight/detail?id=2665323952","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665323952?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:03","pubTimestamp":1788854584,"startTime":"0","endTime":"0","summary":"AlzeCure Pharma to present at Aktiedagen event in StockholmAlzeCure will present at Aktiespararna’s Aktiedagen in Stockholm on Sept. 15.CEO Martin Jnsson is scheduled to speak at 16:25 CEST at Birger ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL83QQ0r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0672654240.SGD","CURE","LU0708995401.HKD","LU2168564065.EUR","LU0786609619.USD","LU0203202063.USD","LU0096364046.USD","LU0210536198.USD","LU2089283258.USD","LU2168564149.EUR","PPH","LU2896262040.SGD","IHE","LU0109394709.USD","LU1551013425.SGD","LU0097036916.USD","LU0158827948.USD","LU0432979614.USD","LU2023250330.USD","LU2462157665.USD","VHT","SG9999018857.SGD","SGXZ31699556.SGD","LU1988902786.USD","LU2360106947.USD","TRUH","LU0289739699.SGD","LU0114720955.EUR","LU0823416689.USD","LU2468319806.SGD","FTXH","LU0385154629.USD","LU2237443465.HKD","IE00BN29S564.USD","LU1057294990.SGD","LU1868837300.USD","LLYX","XLV","AGNG","LU0203201768.USD","LU1035775433.USD","LU0640476718.USD","LU0823434583.USD","SGXZ99366536.SGD","LU0198837287.USD","IE00B4JS1V06.HKD","GB00BDT5M118.USD","LU2168564495.EUR","BK4599","LU2361044865.SGD","SG9999017495.SGD","LU2491049909.HKD","IE00BK4W5M84.HKD","ELIL","LU2462591350.SGD","LU2211815571.USD","LU2461242641.AUD","FHLC","IE00B775H168.HKD","LU0256863902.USD","IE00BKPKM429.USD","LU0345770993.USD","IE0002141913.USD","LU1093756168.USD","LU2552382215.SGD","SG9999014906.USD","LU2271345857.HKD","LU0354030438.USD","LU2028103732.USD","IXJ","LU0174119429.USD","LU0061475181.USD","LU0320765992.SGD","LU1989771016.USD","LU1267930730.SGD","LU2112291526.USD","LU0964807845.USD","HRTS","LU2491050071.SGD","TMED","LU2750360641.GBP","LU2552382132.HKD","SGXZ81514606.USD","IE00BFTCPJ56.SGD","WDNA","LU2265009873.SGD","IE00BK4W5L77.USD","LU0820561818.USD","LU2168564222.USD","LU0106261372.USD","LU0256863811.USD","LU1291159041.SGD","LU2023251221.USD","LU2111349929.HKD","LU2168563687.JPY","LU2756315318.SGD","LU1023059063.AUD","LU1712237335.SGD","SG9999015945.SGD","LU0943347566.SGD","LU0238689110.USD","LU0058720904.USD","LU2456880835.USD","LU2602419157.SGD","JDOC","LU1069344957.HKD","LU2213496289.HKD","IE00BFSS8Q28.SGD","LU2324357040.USD","LU1814569148.SGD","BK4516","BK4007","LU1551013342.USD","LU1917777945.USD","OZEM","PJP","LU1093756325.SGD","LU1868836757.USD","LU1983299246.USD","LU2357305700.SGD","SG9999014914.USD","LU0689472784.USD","LU1548497426.USD","LU2471134523.USD","IE00BJJMRX11.SGD","LU1623119135.USD","LU1061106388.HKD","LU1868836914.USD","IE0001KFT4U8.USD","SG9999018865.SGD","LU2089284900.SGD","LU0683600562.USD","LU2063271972.USD","LU0133085943.USD","LU2491050154.USD","LU2361044949.HKD","GDOC","LU2471134879.HKD","LU2108987350.USD","LU1280957306.USD","IE00B4R5TH58.HKD","LU0471298694.HKD","LU0466842654.USD","LU1323610961.USD","SG9999015978.USD","LU1868836591.USD","LU1974910355.USD","LU2237443382.USD","SG9999001176.SGD","LU0234572021.USD","LU0079474960.USD","LU0456855351.SGD","ELIS","LU2471134796.USD","IE00BJT1NW94.SGD","LU2089984988.USD","LU2237443978.SGD","LU0225283273.USD","LU2552382058.USD","MEDX","IE00BJJMRY28.SGD","LU0320765059.SGD","LU0323591593.USD","LU1232071149.USD","LU1691799644.USD","LU2417539215.USD","LU2746668461.USD","LU1804176565.USD","SG9999015952.SGD","MEDI","ILDR","IE00BJJMRZ35.SGD","LU0823434740.USD","LU1366192091.USD","LU1720051108.HKD","LU2361045086.USD","RXL","IE00BJLML261.HKD","SG9999014898.SGD","LU2237443622.USD","LU0889565916.HKD","SG9999014880.SGD","IE00BFSS7M15.SGD","LU0353189763.USD","LU1629891620.HKD","LU1127390331.HKD","LU0820561909.HKD","LU0882574139.USD","LU0787776722.HKD","LLYZ","IE00B2B36J28.USD","LU0109391861.USD","SGXZ57979304.SGD","LU1979441026.SGD","IE00B7KXQ091.USD","LLII","IE00BWXC8680.SGD","LU2023250504.SGD","BK4588","LU2264538146.SGD","LU1868837136.USD","BK4581","LU2106854487.HKD","SG9999001176.USD","LU2756315664.SGD","LU2236285917.USD","SG9999013999.USD","SG9999015986.USD","LU2087625088.SGD","LU0094547139.USD","BK4534","IE0004445015.USD","LU0158827781.USD","LU2237443549.SGD","IE0004445239.USD","LU1064131342.USD","LU2237438978.USD","LU0266013472.USD","LU2471134952.CNY","LU0316494557.USD","LU0345770308.USD","LLY","LU2237443895.HKD","MHIP","BK4533","IE00B1XK9C88.USD","IE00B1BXHZ80.USD","LU0417517546.SGD","IE00BKDWB100.SGD","SGXZ51526630.SGD","LU1145028129.USD","IE0009355771.USD","THNR","BK4585","CANC","LU0471298777.SGD","LU0820562030.AUD","LU1720051017.SGD","LU2746668974.SGD","IE0005OL40V9.USD","IYH","LU0122379950.USD","LU0882574055.USD","LU2750360997.AUD","LU0353189680.USD","LU0354030511.USD","LU0006306889.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665317041","title":"Gilead Sciences (GILD) Receives a Buy from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2665317041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665317041?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:25","pubTimestamp":1788798346,"startTime":"0","endTime":"0","summary":"Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences today and set a price target of $160.00. Breen covers the Healthcare se...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-receives-a-buy-from-bernstein-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-receives-a-buy-from-bernstein-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1778281490.HKD","LU1934455194.USD","LU1674673428.USD","LU1934455277.USD","IE0002270589.USD","LU1585245621.USD","LU2324357040.USD","BK4139","BK4588","XBI","GILD","BBH","LU0965508806.USD","BMED","BK4585","IBB","LU2089984988.USD","LU2468319806.SGD","SG9999015945.SGD","LU1839511570.USD","IE00BSNM7G36.USD","LU1571399168.USD","LABU","MEDI","IE00B7SZLL34.SGD","LU2112291526.USD","TMED","BK4578","XLV","LU1037948541.HKD","LU0823416689.USD","SG9999015952.SGD","IE00BKVL7J92.USD","SG9999015978.USD","BIB","BK4550","BK4581","BK4566","LU0289739699.SGD","IBBQ","LU0114720955.EUR","LU0882574055.USD","LU0122379950.USD","IE00B3T34201.USD","LU1934455863.HKD","TBXU","LU0234570918.USD","IE00B19Z3B42.SGD","LU1066051498.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185411766","title":"Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids","url":"https://stock-news.laohu8.com/highlight/detail?id=1185411766","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185411766?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:20","pubTimestamp":1788783624,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO.US) announced on Monday that in a late-stage clinical trial, its blockbuster weight-loss drug Wegovy's active ingredient, semaglutide, helped 40.4% of children aged 6 to under 12...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","CURE","RSPH","TRUH","IYH","BGIA","NVOH","NBDS","PINK","NVOC","XLVI","THNR","MEDI","FXH","FHLC","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665023390","title":"ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2665023390","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665023390?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:35","pubTimestamp":1788770131,"startTime":"0","endTime":"0","summary":"ASB Ventures-backed Boundary Zhikong’s Navista eVTOL navigation system enters CAAC airworthiness reviewShenzhen ASB Ventures portfolio company Boundary Intelligent Control secured CAAC acceptance of a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL7rkwzT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","LU0345770993.USD","LU1979441026.SGD","PJP","LU2237443465.HKD","LU0122379950.USD","LU0266013472.USD","LU0882574139.USD","LU1145028129.USD","LU0385154629.USD","SG9999014914.USD","LU2756315318.SGD","LU1691799644.USD","LU1804176565.USD","LU0210536198.USD","LU2063271972.USD","BK4585","ELIS","LU0158827781.USD","IE0002141913.USD","IE0009355771.USD","LU2237443895.HKD","LU0256863902.USD","LU2462591350.SGD","LU0006306889.USD","CANC","LU1551013342.USD","LU2552382215.SGD","SGXZ99366536.SGD","RXL","XLV","AGNG","IE00B4R5TH58.HKD","LU2023251221.USD","LU0823434740.USD","LU0964807845.USD","LU2236285917.USD","SG9999015978.USD","SG9999014906.USD","LU1323610961.USD","LU1868836757.USD","LU1366192091.USD","IE00BKDWB100.SGD","LU1035775433.USD","LU2023250504.SGD","LU2237443978.SGD","THNR","LU2106854487.HKD","IHE","LU2491049909.HKD","ELIL","LU2468319806.SGD","IE0004445239.USD","LU0640476718.USD","LU0158827948.USD","LU2471134796.USD","TMED","LU1023059063.AUD","IE00BFSS7M15.SGD","IE00BFSS8Q28.SGD","BK4588","IE0004445015.USD","IE00B1XK9C88.USD","IE00BJJMRY28.SGD","LU0256863811.USD","LU0787776722.HKD","LU2471134952.CNY","ASB","SG9999018857.SGD","LU2746668974.SGD","LU0823434583.USD","LU0689472784.USD","LU2361044865.SGD","LU0943347566.SGD","LU2265009873.SGD","LU1280957306.USD","LU1989771016.USD","IE00BJJMRX11.SGD","IE0005OL40V9.USD","LU2750360641.GBP","IE00BJT1NW94.SGD","LU0432979614.USD","SG9999015952.SGD","SG9999015986.USD","LU2237443622.USD","LU1720051108.HKD","LU2237443549.SGD","LU0094547139.USD","GDOC","LU1291159041.SGD","LU1988902786.USD","LU2552382132.HKD","IE00B775H168.HKD","LU0466842654.USD","LU0708995401.HKD","LU1069344957.HKD","IE0001KFT4U8.USD","LU2471134879.HKD","SG9999018865.SGD","LU1712237335.SGD","HRTS","LU0114720955.EUR","LU0823416689.USD","LU0456855351.SGD","JDOC","LU2491050071.SGD","LU2168564149.EUR","BK4533","LU2168564222.USD","LU2168564495.EUR","LU2746668461.USD","LU1064131342.USD","LU2756315664.SGD","LU1093756325.SGD","IE00B2B36J28.USD","LU0820561818.USD","FTXH","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU2552382058.USD","LU0198837287.USD","BK4581","LU2237443382.USD","LU1057294990.SGD","BK4534","LU0820562030.AUD","LU2089984988.USD","LU2023250330.USD","LU2360106947.USD","LLYX","LU1061106388.HKD","LU0203202063.USD","SG9999014898.SGD","LU1127390331.HKD","LU2417539215.USD","SGXZ31699556.SGD","SG9999014880.SGD","IE00BN29S564.USD","LU2357305700.SGD","SG9999017495.SGD","LU0061475181.USD","LU2237438978.USD","LU1868837300.USD","LU1232071149.USD","IE00BK4W5M84.HKD","LU0225283273.USD","LU0234572021.USD","LU2456880835.USD","IE00BJJMRZ35.SGD","LU2462157665.USD","LU0786609619.USD","LU2361044949.HKD","LU2750360997.AUD","LU0683600562.USD","SGXZ51526630.SGD","LU0353189763.USD","LU2111349929.HKD","LU1868836591.USD","LU0106261372.USD","TRUH","IE00B7KXQ091.USD","LU1551013425.SGD","MEDI","LU0354030511.USD","LLII","BK4007","LU1983299246.USD","LU0889565916.HKD","LU0820561909.HKD","LU2461242641.AUD","LU0203201768.USD","LU0133085943.USD","GB00BDT5M118.USD","SG9999015945.SGD","LU0345770308.USD","LU1093756168.USD","LU1629891620.HKD","LU2361045086.USD","IXJ","LU0058720904.USD","LU2471134523.USD","LU2491050154.USD","LU0174119429.USD","LU1720051017.SGD","OZEM","LU0316494557.USD","LU0096364046.USD","LU2264538146.SGD","LU0471298694.HKD","SGXZ57979304.SGD","LU2089284900.SGD","LLY","CURE","LU0471298777.SGD","LU1814569148.SGD","LU2028103732.USD","LU2324357040.USD","WDNA","LU1917777945.USD","LU2271345857.HKD","LU0289739699.SGD","LU2089283258.USD","LU2211815571.USD","PPH","IE00B1BXHZ80.USD","LU2896262040.SGD","LU0323591593.USD","SG9999001176.USD","SG9999013999.USD","MHIP","LU2168564065.EUR","LU1974910355.USD","LU0672654240.SGD","LU0417517546.SGD","LU1548497426.USD","LU1623119135.USD","VHT","FHLC","BK4211","LU2108987350.USD","LU2112291526.USD","IE00BJLML261.HKD","LU0353189680.USD","IE00BK4W5L77.USD","LU1868836914.USD","LU1868837136.USD","LU0109394709.USD","MEDX","SG9999001176.SGD","LU0109391861.USD","LU0079474960.USD","LLYZ","LU0320765059.SGD","LU0882574055.USD","IE00BWXC8680.SGD","LU2087625088.SGD","LU2602419157.SGD","BK4516","LU2168563687.JPY","LU0097036916.USD","IE00B4JS1V06.HKD","LU0238689110.USD","ILDR","LU1267930730.SGD","LU2213496289.HKD","IYH","IE00BKPKM429.USD","SGXZ81514606.USD","LU0354030438.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665390614","title":"Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665390614","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665390614?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768672,"startTime":"0","endTime":"0","summary":"UPDATE 2-Novartis cholesterol setback tests hopes for emerging heart disease drugsLONDON, Sept 7 (Reuters)-Shares of NovartisNOVN.Sfell more than 3% on Monday after its cholesterol drug failed in a cl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL1N44Z05O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0097036916.USD","MEDX","LU2361044865.SGD","THNR","LLY","AGNG","IBB","WDNA","LLII","IXJ","LU1691799644.USD","FHLC","MHIP","LU1267930730.SGD","SGXZ99366536.SGD","IBBQ","LU0823434583.USD","ELIL","IYH","LLYZ","BIB","LU1571399168.USD","OZEM","PPH","RXL","VHT","PBE","ELIS","LU2750360641.GBP","AMGN","IHE","NAMS","TBXU","BBH","FTXH","LLYX","MEDI","CURE","CANC","HRTS","GDOC","XLV","TMED","TRUH","LU2089284900.SGD","PJP","JDOC","IE00BJJMRY28.SGD","SLN","ILDR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665354019","title":"Guardant announces FDA approval of Guardant360 CDx as companion diagnostic","url":"https://stock-news.laohu8.com/highlight/detail?id=2665354019","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665354019?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:15","pubTimestamp":1788560112,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced that the U.S. Food and Drug Administration has approved Guardant360 CDx as a companion diagnostic to identify patien...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","PTH","GNMX","MEDI","FFOX","EKG","BK4535","GNOM","XLVX","BBP","IDNA","GDOC","TECB","NVIB","PINK","HELX","MRNX","LU0889565916.HKD","TBXU","LU0320765992.SGD","BK4196","LABU","GH","LU0109394709.USD","BK4551","FRTY","IEIH","IBB","SYNB","IYH","BK4588","RSPH","BMED","MRNY","LFSC","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665351836","title":"Healthcare Stocks Pick up Steam as Investors Play Offense and Defense","url":"https://stock-news.laohu8.com/highlight/detail?id=2665351836","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665351836?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:22","pubTimestamp":1788553320,"startTime":"0","endTime":"0","summary":"Want a prescription for investing success?","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836914.USD","LU0786609619.USD","BK4599","BK4585","BK4007","BK4581","LU0432979614.USD","LU0820562030.AUD","LU2028103732.USD","LU2168564149.EUR","LU0353189763.USD","GB00BDT5M118.USD","BK4501","LU1629891620.HKD","LU1814569148.SGD","HRTS","LU2461242641.AUD","LLYZ","IE00BFSS8Q28.SGD","LU0122379950.USD","LLII","LU0158827781.USD","LU2756315318.SGD","SG9999015952.SGD","LU1868837300.USD","SGXZ81514606.USD","IE00BN29S564.USD","BK4532","LU2106854487.HKD","LU2357305700.SGD","IE00B775H168.HKD","LU2750360641.GBP","PPH","LU2063271972.USD","THNR","LU0079474960.USD","IE00B1XK9C88.USD","LU1868836591.USD","LU1093756325.SGD","LU0256863811.USD","ELIS","LU2089283258.USD","LU0320765992.SGD","LU2168563687.JPY","LU2471134796.USD","LU2552382058.USD","LU1720051108.HKD","LU0466842654.USD","IE0004445239.USD","SGXZ51526630.SGD","LU0234572021.USD","LU2746668461.USD","LU1983299246.USD","LLYX","LU0174119429.USD","LU0345770308.USD","LU0787776722.HKD","LU1868837136.USD","LU0354030511.USD","LU2756315664.SGD","IE00BFTCPJ56.SGD","LU0471298694.HKD","SG9999015978.USD","LU1551013342.USD","LU2023251221.USD","FTXH","LU0238689110.USD","LU1280957306.USD","TMED","LU2236285917.USD","SG9999001176.USD","IE00B1BXHZ80.USD","LU0823434740.USD","BK4533","LU2896262040.SGD","RXL","JDOC","LU1035775433.USD","LGHT","LU0289739699.SGD","LU2168564222.USD","LU2211815571.USD","LU2237443622.USD","TRUH","LU0708995401.HKD","LU2111349929.HKD","LU0820561909.HKD","LU1868836757.USD","SG9999014914.USD","IE0004445015.USD","LU0823416689.USD","IE00BKDWB100.SGD","LU0006306889.USD","LU2456880835.USD","LU1291159041.SGD","MRNX","LU1623119135.USD","LU0345770993.USD","IE00BKPKM429.USD","BK4139","LU0266013472.USD","LU1366192091.USD","LU0109394709.USD","LU2491049909.HKD","IE00B4R5TH58.HKD","LU0198837287.USD","LU2552382132.HKD","SGXZ99366536.SGD","SG9999018865.SGD","LU2237443382.USD","BK4568","LU1712237335.SGD","LU0106261372.USD","LU1127390331.HKD","LU1551013425.SGD","LU1917777945.USD","LU2417539215.USD","LU0683600562.USD","LU0820561818.USD","LU2213496289.HKD","SGXZ57979304.SGD","LU0109391861.USD","BK4548","LU0640476718.USD","LU2108987350.USD","LU2089284900.SGD","LU0385154629.USD","GDOC","SGXZ31699556.SGD","IE00BK4W5L77.USD","SG9999014906.USD","LU0882574139.USD","IHE","LU2168564495.EUR","LU0471298777.SGD","LU2471134952.CNY","LU0096364046.USD","LU2746668974.SGD","LU0889565916.HKD","LU0316494557.USD","LU2468319806.SGD","LU2471134879.HKD","LU0133085943.USD","LU2324357040.USD","OZEM","LU2360106947.USD","LU1093756168.USD","LU2602419157.SGD","LU2237443978.SGD","LU0061475181.USD","LU0114720955.EUR","IE00BJLML261.HKD","LU0203201768.USD","LU1232071149.USD","MRNA","LU0320765059.SGD","LLY","SG9999014880.SGD","LU2168564065.EUR","IE00B2B36J28.USD","PJP","LU0058720904.USD","IE0002141913.USD","IE00BFSS7M15.SGD","BK4534","LU1979441026.SGD","FHLC","IE00B7KXQ091.USD","IE00BJT1NW94.SGD","ILDR","LU1057294990.SGD","LU2087625088.SGD","LU0210536198.USD","LU2089984988.USD","LU2264538146.SGD","LU2462157665.USD","LU1069344957.HKD","MEDX","LU2361045086.USD","MEDI","SG9999017495.SGD","LU2361044865.SGD","IE0005OL40V9.USD","LU0417517546.SGD","LU1989771016.USD","BK4588","BK4516","MRNY","LU1974910355.USD","SG9999001176.SGD","LU2237443549.SGD","ELIL","IDNA","WDNA","LU0964807845.USD","LU2471134523.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU0823434583.USD","AGNG","CANC","LU2112291526.USD","LU2552382215.SGD","LU2023250504.SGD","LU2023250330.USD","LU1804176565.USD","LU2237438978.USD","LU2491050071.SGD","LU0672654240.SGD","LU2750360997.AUD","IHF","LU0943347566.SGD","BK4551","LU2462591350.SGD","IE0001KFT4U8.USD","XBI","SG9999014898.SGD","LU0689472784.USD","LU1323610961.USD","LU0256863902.USD","IE0009355771.USD","IBB","LU0353189680.USD","LU1988902786.USD","LU2237443465.HKD","MHIP","LU1720051017.SGD","LU2265009873.SGD","SG9999013999.USD","IE00BWXC8680.SGD","LU0094547139.USD","SG9999015986.USD","SG9999018857.SGD","LU1691799644.USD","GNOM","LU1061106388.HKD","IE00BK4W5M84.HKD","LU0203202063.USD","LU0354030438.USD","LABU","LU2237443895.HKD","IE00BJJMRY28.SGD","LU1267930730.SGD","LU2271345857.HKD","IE00BJJMRX11.SGD","LU2491050154.USD","LU2361044949.HKD","LU1064131342.USD","LU0456855351.SGD","LU0882574055.USD","IE00B4JS1V06.HKD","LU1548497426.USD","SG9999015945.SGD","XLV","LU0225283273.USD","LU0158827948.USD","LU0323591593.USD","LU1145028129.USD","LU0097036916.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665135376","title":"Lilly Targets Type 1 Diabetes With New Tirzepatide Study: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2665135376","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665135376?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:31","pubTimestamp":1788539464,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Eli Lilly and Company (LLY) is launching a new Phase 1 study on t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lilly-targets-type-1-diabetes-with-new-tirzepatide-study-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lilly-targets-type-1-diabetes-with-new-tirzepatide-study-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0158827781.USD","LU0097036916.USD","LU1974910355.USD","ILDR","LU2602419157.SGD","WDNA","LU0158827948.USD","LU0345770308.USD","LU2552382058.USD","LU0114720955.EUR","LU1629891620.HKD","TRUH","IE00BK4W5M84.HKD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU2168564222.USD","LU0786609619.USD","LU0122379950.USD","IHE","ELIS","LU2471134523.USD","LU0006306889.USD","LU0964807845.USD","LU2237443978.SGD","IE00B4JS1V06.HKD","LU2108987350.USD","BK4516","LU0320765059.SGD","LU0672654240.SGD","LU1064131342.USD","LU2112291526.USD","BK4588","LU1548497426.USD","LU0320765992.SGD","LU0225283273.USD","LU1917777945.USD","LU0823416689.USD","HRTS","LU1551013425.SGD","LU0094547139.USD","LU2168564495.EUR","LU1712237335.SGD","IE00B1XK9C88.USD","LU0708995401.HKD","LU2237443465.HKD","LU2028103732.USD","LU2063271972.USD","LU2491049909.HKD","LU0203201768.USD","LU1988902786.USD","LU0820561909.HKD","LU0471298694.HKD","LU1720051108.HKD","LU2089984988.USD","BK4599","OZEM","SG9999001176.SGD","IE00BFSS7M15.SGD","IYH","LU1093756168.USD","LU2213496289.HKD","IE00B1BXHZ80.USD","LU1691799644.USD","LU1366192091.USD","LU2324357040.USD","IXJ","LU2471134879.HKD","LU2089283258.USD","LLYZ","LU0096364046.USD","IE00B2B36J28.USD","LU0256863811.USD","MEDI","SG9999015952.SGD","SGXZ99366536.SGD","IE00B4R5TH58.HKD","SGXZ51526630.SGD","LU2552382132.HKD","LU2417539215.USD","LU0787776722.HKD","LU0823434740.USD","ELIL","LU1868836757.USD","LU2552382215.SGD","LU1145028129.USD","SG9999017495.SGD","LU0889565916.HKD","LU1989771016.USD","LU0174119429.USD","LU2471134952.CNY","LU0058720904.USD","SG9999018865.SGD","BK4585","FHLC","LU2023250504.SGD","GDOC","RXL","IE0005OL40V9.USD","SG9999014914.USD","IE00BKDWB100.SGD","IE00BKPKM429.USD","LU0820562030.AUD","BK4534","LU0466842654.USD","LU1868837300.USD","IE00BWXC8680.SGD","LU1232071149.USD","IE00BJJMRX11.SGD","LU2357305700.SGD","LU2361045086.USD","LU2237443895.HKD","JDOC","SG9999015978.USD","LLYX","IE00BJLML261.HKD","LU0640476718.USD","LU0689472784.USD","GB00BDT5M118.USD","IE00BJJMRY28.SGD","LU0109391861.USD","LU2361044949.HKD","LU2087625088.SGD","SG9999014880.SGD","LU0823434583.USD","LU2468319806.SGD","LU1023059063.AUD","LU2265009873.SGD","LU2462591350.SGD","IE00B7KXQ091.USD","LU0385154629.USD","PJP","SG9999013999.USD","SG9999018857.SGD","LU0353189763.USD","SG9999014906.USD","SG9999015945.SGD","LU2237438978.USD","LU2111349929.HKD","LU2236285917.USD","LU1093756325.SGD","LU1814569148.SGD","LU2896262040.SGD","LU0106261372.USD","LU1623119135.USD","LU2237443549.SGD","LU0456855351.SGD","LU2461242641.AUD","LU2456880835.USD","LU0471298777.SGD","LU2106854487.HKD","SG9999015986.USD","LU0820561818.USD","MEDX","LLY","LU2089284900.SGD","SGXZ81514606.USD","LU2168564065.EUR","LU0266013472.USD","LU1868836914.USD","LU1979441026.SGD","VHT","LU2360106947.USD","IE00BN29S564.USD","LU2023250330.USD","SG9999014898.SGD","LU2462157665.USD","LU0316494557.USD","LU1061106388.HKD","LU0943347566.SGD","IE00BK4W5L77.USD","XLV","LU1868836591.USD","IE0004445015.USD","LU2237443622.USD","LU1720051017.SGD","LU2756315318.SGD","MHIP","LU2023251221.USD","IE00BFTCPJ56.SGD","SGXZ31699556.SGD","LU0683600562.USD","TMED","LLII","LU1868837136.USD","LU2471134796.USD","IE0001KFT4U8.USD","LU2746668974.SGD","IE00B775H168.HKD","PPH","IE00BFSS8Q28.SGD","LU1291159041.SGD","LU1035775433.USD","LU2271345857.HKD","LU2211815571.USD","LU1983299246.USD","LU0079474960.USD","IE0002141913.USD","LU0345770993.USD","LU0354030438.USD","LU2750360641.GBP","SG9999001176.USD","LU0289739699.SGD","AGNG","LU2168564149.EUR","LU0061475181.USD","LU0198837287.USD","BK4533","LU1551013342.USD","LU2237443382.USD","LU2746668461.USD","FTXH","BK4581","LU0210536198.USD","LU0256863902.USD","LU1069344957.HKD","LU0417517546.SGD","LU2491050071.SGD","CURE","LU0432979614.USD","LU0238689110.USD","CANC","LU0203202063.USD","LU0323591593.USD","LU2361044865.SGD","THNR","LU2756315664.SGD","SGXZ57979304.SGD","LU1127390331.HKD","LU0354030511.USD","LU1267930730.SGD","LU2491050154.USD","LU1323610961.USD","LU2264538146.SGD","LU1057294990.SGD","BK4007","LU0882574055.USD","LU0133085943.USD","LU2168563687.JPY","LU0109394709.USD","LU0353189680.USD","LU0882574139.USD","IE0004445239.USD","LU2750360997.AUD","LU0234572021.USD","IE00BJT1NW94.SGD","LU1280957306.USD","LU1804176565.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664012018","title":"Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2664012018","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664012018?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:35","pubTimestamp":1788467700,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  advanced 1.08% to $151.22 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.06% to 7,747.71 and the Dow Jones Industrial Average  rising 1.18% to 53,686.11.Gilead Sciences Inc. closed 3.86% short of its 52-week high of $157.29, which the company reached on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  rose 1.17% to $278.43, Pfizer Inc.  fell 0.72% to $28.81, and Abbott Laboratories  fell 1.52% to $108.79.Trading volume  remained 2.3 million below its 50-day average volume of 6.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 3, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015986.USD","BK4566","LU0320765992.SGD","LU0965509101.SGD","IBBQ","LU0965509283.SGD","LU0109394709.USD","SG9999015952.SGD","LU1934455863.HKD","LU0058720904.USD","LU1585245621.USD","LU0889565916.HKD","SG9999015978.USD","LU0122379950.USD","LU2089984988.USD","BK4583","BBH","BK4585","LU0289739699.SGD","LU1839511570.USD","BK4568","LU1674673691.USD","IE00B19Z3581.USD","IBB","LU1057294990.SGD","LU1037948541.HKD","LU1061106388.HKD","SG9999015945.SGD","IE00B19Z3B42.SGD","LU0859254822.USD","GILD","LU1778281490.HKD","LU0823416689.USD","BK4139","IE00BZ1G4Q59.USD","LU1934455277.USD","LU2357627491.SGD","BK4532","TBXU","LU1066053197.SGD","MEDI","BMED","LU0114720955.EUR","LU2112291526.USD","LU1571399168.USD","LU2324357040.USD","LU0965508806.USD","LU1430594728.SGD","LU0882574055.USD","LU1023059063.AUD","BK4550","LU2468319806.SGD","IE00BKVL7J92.USD","TMED","LU1037948897.HKD","LU0965509010.AUD","BK4578","LU0861579265.USD","LU2087621335.USD","LU1066051498.USD","BK4588","LU1674673428.USD","LU1934455194.USD","IE00BSNM7G36.USD","IE0002270589.USD","LU0234570918.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664018048","title":"Ascendis Pharma Director Lars Holtug Disposes of 236 Shares Worth $62,337.59","url":"https://stock-news.laohu8.com/highlight/detail?id=2664018048","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664018048?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:10","pubTimestamp":1788466204,"startTime":"0","endTime":"0","summary":"Ascendis Pharma director Lars Holtug disposes of 236 shares worth $62,337.59Ascendis Pharma director Lars Holtug sold 236 ordinary shares on Sep. 2, 2026 at USD 264.13 each.Directly held stake fell to","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL4sXtKL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Ascendis Pharma Director Lars Holtug Disposes of 236 Shares Worth $62,337.59","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ASND","LU0320765992.SGD","LU0889565916.HKD","MEDI","LU0109394709.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}